Catherine Lindon
Catherine Lindon
Research group leader, University of Cambridge, UK
Verified email at - Homepage
Cited by
Cited by
Active cyclin B1–Cdk1 first appears on centrosomes in prophase
M Jackman, C Lindon, EA Nigg, J Pines
Nature cell biology 5 (2), 143-148, 2003
Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells
C Lindon, J Pines
The Journal of cell biology 164 (2), 233-241, 2004
Spastin couples microtubule severing to membrane traffic in completion of cytokinesis and secretion
JW Connell, C Lindon, JP Luzio, E Reid
Traffic 10 (1), 42-56, 2009
Early mitotic degradation of Nek2A depends on Cdc20-independent interaction with the APC/C
MJ Hayes, Y Kimata, SL Wattam, C Lindon, G Mao, H Yamano, AM Fry
Nature cell biology 8 (6), 607-614, 2006
Characterization and expression of mammalian cyclin b3, a prepachytene meiotic cyclin
TB Nguyen, K Manova, P Capodieci, C Lindon, S Bottega, XY Wang, ...
Journal of Biological Chemistry 277 (44), 41960-41969, 2002
APC/CCdh1 targets aurora kinase to control reorganization of the mitotic spindle at anaphase
S Floyd, J Pines, C Lindon
Current Biology 18 (21), 1649-1658, 2008
Cell cycle–regulated expression of the muscle determination factor Myf5 in proliferating myoblasts
C Lindon, D Montarras, C Pinset
The Journal of cell biology 140 (1), 111-118, 1998
The Aurora-A/TPX2 complex: a novel oncogenic holoenzyme?
IA Asteriti, WM Rensen, C Lindon, P Lavia, G Guarguaglini
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1806 (2), 230-239, 2010
Proteolysis: anytime, any place, anywhere?
J Pines, C Lindon
Nature cell biology 7 (8), 731-735, 2005
A quantitative protocol for dynamic measurements of protein interactions by Förster resonance energy transfer-sensitized fluorescence emission
AD Elder, A Domin, GS Kaminski Schierle, C Lindon, J Pines, A Esposito, ...
Journal of The Royal Society Interface 6 (suppl_1), S59-S81, 2009
Control of Aurora-A stability through interaction with TPX2
M Giubettini, IA Asteriti, J Scrofani, M De Luca, C Lindon, P Lavia, ...
Journal of cell science 124 (1), 113-122, 2011
Cultured myf5 null and myoD null muscle precursor cells display distinct growth defects
D Montarras, C Lindon, C Pinset, P Domeyne
Biology of the Cell 92 (8‐9), 565-572, 2000
Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci
O Albagli, D Lantoine, S Quief, F Quignon, C Englert, JP Kerckaert, ...
Oncogene 18 (36), 5063-5075, 1999
Uncoupling anaphase-promoting complex/cyclosome activity from spindle assembly checkpoint control by deregulating polo-like kinase 1
BCM van de Weerdt, MATM van Vugt, C Lindon, JJW Kauw, ...
Molecular and cellular biology 25 (5), 2031-2044, 2005
Efficient APC/C substrate degradation in cells undergoing mitotic exit depends on K11 ubiquitin linkages
M Min, TET Mevissen, M De Luca, D Komander, C Lindon
Molecular biology of the cell 26 (24), 4325-4332, 2015
Ubiquitin-mediated degradation of aurora kinases
C Lindon, R Grant, M Min
Frontiers in Oncology 5, 307, 2016
Ubiquitination site preferences in anaphase promoting complex/cyclosome (APC/C) substrates
M Min, U Mayor, C Lindon
Open biology 3 (9), 130097, 2013
Activating transcription factor-1 is a specific antagonist of the cyclic adenosine 3'. 5'-monophosphate (cAMP) response element-binding protein-1-mediated response to cAMP.
MJ Ellis, AC Lindon, KJ Flint, NC Jones, S Goodbourn
Molecular Endocrinology 9 (2), 255-265, 1995
Using in vivo biotinylated ubiquitin to describe a mitotic exit ubiquitome from human cells
M Min, U Mayor, G Dittmar, C Lindon
Molecular & Cellular Proteomics 13 (9), 2411-2425, 2014
Control of mitotic exit and cytokinesis by the APC/C
C Lindon
Biochemical Society Transactions 36 (3), 405-410, 2008
The system can't perform the operation now. Try again later.
Articles 1–20